Sigachi Industries Ltd
Q3 FY25 Earnings Call Analysis
Pharmaceuticals & Biotechnology
fundraise: Yescapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- The company is seeking shareholder approval for raising debt up to Rs.1,000 crores in the near future, primarily as a borrowing limit for future requirements, not immediate full utilization.
- Debt drawdowns will be made as needed, with board approval; it may include bank loans or Non-Convertible Debentures (NCDs).
- The higher debt limit ensures availability of working capital and flexibility to seize opportunities without delay.
- No direct immediate plans to raise the entire Rs.1,000 crores debt; current working capital limits stand at Rs.200 crores with around Rs.130 crores utilized.
- Regarding equity fundraising, the company indicated possible plans including preferential share issues but has not disclosed specific details or timing; board approval required prior to any equity infusion.
- Promoters intend to participate in future fundraisings to increase their stake and reduce pledging.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- MCC 12,000 metric tons facility expansion planned with a CAPEX of around Rs.100 crores, expected to generate Rs.250 crores revenue at full capacity. (Page 20)
- CCS facility requires approximately Rs.60 crores additional CAPEX; Rs.33 crores already available; implementation ongoing. (Page 20)
- Orvakal facility plans are under consideration (API/MCC), with environmental clearance expected within 30 days; final decisions pending board approval. (Page 19)
- Minor capital spends planned on safety improvements and process upgrades across existing plants; no significant CAPEX expected for this. (Page 17)
- Company is strengthening operations and advancing expansion projects aiming to become a fully integrated pharma company. (Page 24)
- Debt approval sought up to Rs.1,000 crores for future financial flexibility related to CAPEX and working capital, actual debt to be drawn as required. (Page 22 & 16)
📊revenue
Future growth expectations in sales/revenue/volumes?
- Sigachi aims for consistent and sustainable growth over the next 2-3 years driven by excipients, APIs, and O&M services. (Page 5)
- The company expects to achieve not less than Rs.575 crore revenue by FY26 with potential for further increase by March-end. (Page 18)
- An additional 12,000 metric tons capacity expansion planned, expected to generate around Rs.250 crore in revenue moving forward. (Page 18)
- FY27 will see partial revenue contributions from the new capacity along with regular growth from existing operations. (Page 18)
- Despite disruptions, the company expects Q3 and Q4 to stabilize and improve growth momentum. (Page 15, 18)
- API business revenue contribution is growing, expected to increase gradually alongside MCC and O&M segments. (Page 14)
- The company is also exploring new plant setups and expansions, such as at Orvakal, pending government approvals. (Page 19)
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company aims for consistent and sustainable growth over the next 2-3 years driven by excipients, APIs, and O&M services.
- Expansion of capacity, strengthening product mix, and enhancing profitability through operational excellence and disciplined execution are key focus areas.
- The additional 12,000 metric tons MCC capacity is expected to generate peak revenue of around Rs. 250 crores.
- Margins for CCS facility are expected to be higher than MCC, targeting around 30% EBITDA level.
- FY26 revenue is expected not to be less than Rs. 575 crores and could increase further by year-end.
- Growth may face small disturbances in FY26 Q3 and Q4 but expected to stabilize and improve onwards.
- Debt funding and possible equity infusion will support expansion and working capital needs without guaranteed full utilization of Rs. 1,000 crore debt approval.
- Overall, disciplined execution and capacity expansion underpin confidence in sustained value creation.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
The transcript does not provide explicit details regarding the current or expected order book or pending orders for Sigachi Industries Limited. However, the following relevant insights can be noted:
- The company faces a recent shortfall in production due to a fire incident but is addressing it by prioritizing critical customers who do not have alternate suppliers.
- Customers have shown mutual understanding, with some shifting to alternate suppliers temporarily until Sigachi's capacities are restored.
- The company is expanding capacity, including a 12,000 metric tons MCC facility expected to generate Rs.250 crores revenue.
- Environmental clearance for the Orvakal facility is expected soon, indicating potential future expansions.
- The company maintains strong repeat business, with 80-90% repeat customers, suggesting a stable ongoing order inflow.
- Sigachi emphasizes operational stabilization, safety improvements, and capacity ramp-up to meet future demand.
No specific numerical data on the pending or booked orders was disclosed in the earnings call transcript.
